What is the CVSS score of CVE-2023-26546?

CVE-2023-26546 has a CVSS 3.1 base score of 8.8 (High). CVSS vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H. EPSS exploitation probability: 1.4%.

Iuclid CVE-2023-26546

HIGH

Code Injection (CWE-94)

2023-05-02 cve@mitre.org

RCE Code Injection Iuclid

8.8

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

8.8 HIGH

AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Attack Vector

Network

Attack Complexity

Low

Privileges Required

Low

User Interaction

None

Scope

Unchanged

Confidentiality

High

Integrity

High

Availability

High

Lifecycle Timeline

CVE Published

May 02, 2023 - 20:15 nvd

HIGH 8.8

DescriptionNVD

European Chemicals Agency IUCLID before 6.27.6 allows remote authenticated users to execute arbitrary code via Server Side Template Injection (SSTI) with a crafted template file. The attacker must have template manager permission.

AnalysisAI

European Chemicals Agency IUCLID before 6.27.6 allows remote authenticated users to execute arbitrary code via Server Side Template Injection (SSTI) with a crafted template file. Rated high severity (CVSS 8.8), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

Technical ContextAI

This vulnerability is classified as Code Injection (CWE-94), which allows attackers to inject and execute arbitrary code within the application. European Chemicals Agency IUCLID before 6.27.6 allows remote authenticated users to execute arbitrary code via Server Side Template Injection (SSTI) with a crafted template file. The attacker must have template manager permission. Affected products include: Echa.Europa Iuclid. Version information: before 6.27.6.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Never evaluate user-controlled input as code. Use sandboxing, disable dangerous functions, apply strict input validation.